| 201299-92-5 | 1H-Pyrazole, 1-(2-chloro-1-oxopropyl)-3,5-dimethyl- (9CI) |
| 201299-94-7 | 1H-Indazole, 1-(2-chloro-1-oxopropyl)- (9CI) |
| 201304-22-5 | 4-[4-[4-(AMINOIMINOMETHYL)PHENYL]-1-PIPERAZINYL]-1-PIPERIDINEACETIC ACID TRIHYDROCHLORIDE |
| 201305-16-0 | C18-C22-Alkyl-4-hydroxybenzoat |
| 201305-18-2 | PPG-1 HYDROXYETHYL CAPRYLAMIDE |
| 201334-78-3 | DI-TERT-BUTYL-DIETHOXYSILANE |
| 201334-88-5 | BOC-DL-TYR(2,6-DICHLORO-BZL)-OH |
| 201335-88-8 | FMOC-D-4-METHOXYPHE |
| 201335-92-4 | FMOC-D-TYR(PO3ME2)-OH |
| 201336-54-1 | L-BETA-PHENYLLACTOYL-TYR-OH |
| 201337-81-7 | Cyclopropanecarboxylic acid, 2-[(acetyloxy)methyl]-, (1R-trans)- (9CI) |
| 201338-62-7 | METHYL 2-(BIS[(TERT-BUTOXY)CARBONYL]AMINO)PROP-2-ENOATE(WXG03125) |
| 201338-72-9 | 1,2-Cyclopropanedicarboxylicacid,1-amino-,2-ethyl1-methylester,cis-(9CI) |
| 201339-97-1 | 2-Penten-4-yn-1-amine,N,N,3-trimethyl-,(2E)-(9CI) |
| 201340-97-8 | Tenofovir disoproxil Impurity 44 |
| 201341-01-7 | Tenofovir prodrug |
| 201341-05-1 | Tenofovir disoproxil |
| 201346-23-8 | HEPTAKIS(2 3-DI-O-METHYL-6-O-SULFO)-(B)& |
| 201349-37-3 | 1-Methyl-4-[[(phenylmethyl)amino]carbonyl]pyridinium iodide |
| 201349-60-2 | 5-(4-Aminonaphthalen-1-yl)-furan-2-carboxylic acid |
| 201351-32-8 | AC-DAB(BOC)-OH |
| 201351-59-9 | AC-P-IODO-D-PHE-OH |
| 201353-89-1 | H-ALLO-THR(TBU)-OH |
| 201354-21-4 | N-(3-acetylphenyl)thiophene-2-carboxamide |
| 201354-26-9 | H-AAD(OTBU)-OH |
| 201360-82-9 | Desogestrel delta-3 isoMer |
| 201360-83-0 | Desogestrel IMpurity |
| 201363-05-5 | 1,2,4-Thiadiazol-3-amine,4,5-dihydro-4-methyl-,1,1-dioxide(9CI) |
| 201363-52-2 | PPG-2 HYDROXYETHYL COCAMIDE |
| 201402-98-4 | Decahydro-3soquinolineCarboxamideMonoBenzoate,NelfinavirMesylate, |
| 201403-02-3 | b-AMino-4-broMobenzeneethanol |
| 201403-46-5 | PROXYL-MTS |
| 201404-15-1 | N-(Acetyl-d3)-S-benzyl-L-cysteine |
| 201404-26-4 | DIETHYL 2-(4-CYANOPHENYL)MALONATE |
| 201404-37-7 | Pyrrolo[1,2-a]pyrazine, 1,2,3,4-tetrahydro-1-methylene- (9CI) |
| 201404-86-6 | (R)-TERT-BUTYL 4-(2-HYDROXYETHYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE |
| 201406-01-1 | butyl [(5-oxo-3-thioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl)amino]acetate |
| 201406-78-2 | Proline, 1-(phenylmethyl)-, methyl ester |
| 201408-35-7 | 3-(3,4-DIMETHOXYPHENYL)-DL-BETA-ALANINOL
|
| 201408-36-8 | 3-AMINO-3-(3-ETHOXY-4-METHOXY-PHENYL)-PROPIONIC ACID |
| 201409-17-8 | Ondansetron EP Impurity H |
| 201409-23-6 | N-[N-methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl]-L-valine，Lithium Salt |
| 201409-47-4 | (3aS,8aR)-2-(2-diphenylphosphinophenyl)-3a,8a-dihydroindane[1,2-d]oxazole |
| 201410-24-4 | 4-(3-DIMETHYLAMINO-2-METHYLPROPIONYL)ACETANILIDE |
| 201410-53-9 | R 115866 |
| 201410-66-4 | (+)-Talarozole |
| 201410-67-5 | (-)-Talarozole |
| 201411-99-6 | 2-phenethyl-1H-benzo[d]imidazole-7-carboxylic acid(WXG00120) |
| 201412-32-0 | Benzoic acid, 2,3-diamino-5-fluoro-, ethyl ester (9CI) |
| 201415-26-1 | FENTANYL-D5 |
| 201415-38-5 | 5-PHENYL-BENZOOXAZOLE |
| 201415-63-6 | 1-(4-Chloro-phenyl)-3-phenyl-3-(toluene-4-sulfonyl)-propan-1-one |
| 201416-09-3 | 4-BROMO-3-METHOXY-2-NAPHTHOIC ACID |
| 201416-29-7 | BUTTPARK 78\40-46 |
| 201416-66-2 | BOC-3,5-DIIODO-TYR(2',6'-DICHLORO-BZL)-OH |
| 201417-01-8 | D-GLUCOSE-13C6-1 2 3 4 5 6 6-D7 |
| 201417-02-9 | 2,2,5,5-D4, 96+) |
| 201417-04-1 | LINDANE (13C6) |
| 201417-06-3 | D-[1-13C,2-2H]GLUCOSE |
| 201417-11-0 | CYTOSINE (2-13C, 99) |
| 201417-12-1 | L-DOPA (Ring-13C6, 99) |
| 201418-83-9 | BOC-HCI-OH |
| 201419-15-0 | (S)-2-(BOC-AMINO)-4-(4-METHYL-BENZYLSULFANYL)BUTYRIC ACID |
| 201419-16-1 | BOC-HOMOCYS(TRT)-OH |
| 201419-80-9 | 2,4,8,10-Tetraoxa-3,9-dithiaspiro[5.5]undecane, 3,3,9,9-tetraoxide |
| 201420-30-6 | 4-Chloro-3-quinolinecarboxaldehyde |
| 201420-31-7 | 6-BROMO-4-CHLOROQUINOLINE-3-CARBALDEHYDE |
| 201420-91-9 | Boc-N-Me-Phe(4-NO2)-OH·DCHA |
| 201421-00-3 | 2',3',5'-Tri-O-acetyl-5,N3-dimethyluridine |
| 201421-14-9 | BOC-D-PEN(ACM)-OH |
| 201421-82-1 | 2H-Cyclopenta[b]furan-4-carboxaldehyde, hexahydro-2-oxo-, [3aR-(3aalpha,4alpha,6aalpha)]- (9CI) |
| 201422-03-9 | PROTEIN KINASE A INHIBITOR 14-22 AMIDE, CELL-PERMEABLE, MYRISTOYLATED |
| 201422-04-0 | Autocamtide-2-related inhibitory peptide, myristoylated |
| 201422-05-1 | BIOTIN-LC-PTYR-GLU-GLU-ILE-OH |
| 201423-46-3 | 2-Pentanone, 5-(ethenyloxy)-3-methyl- (9CI) |
| 201423-59-8 | Pravastatin 6'-Ketone SodiuM Salt |
| 201424-15-9 | methyl 3-(hydroxymethyl)cyclohexane-1-carboxylate |
| 201424-86-4 | 2-amino-4-ethyl-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile |
| 201464-10-0 | 3,4-Dihydroxy-2,5-dimethoxytetrahydrofuran |
| 201465-62-5 | 3-Pyridineacetonitrile,alpha-carbonyl-(9CI) |
| 201466-03-7 | H-D-BPA-OH |
| 201466-35-5 | Loratadine Impurity 13 |
| 201467-81-4 | N33-TEG-COOH |
| 201467-93-8 | N-[4-METHYL-7-METHOXYCOUMARIN]-N,N,N-TRIBUTYLAMMONIUM TETRAPHENYLBORATE |
| 201467-95-0 | N-(4-ACETYLBENZYL)-N,N,N-TRIMETHYL AMMONIUM TETRAPHENYLBORATE |
| 201467-96-1 | N-(4-ACETYLBENZYL)-N,N,N-TRIMETHYL AMMONIUM BUTYLTRIPHENYL BORATE |
| 201467-99-4 | N-(2-NAPHTHYL METHYL)-N,N,N-TRIBUTYL AMMONIUM BUTYLTRIPHENYL BORATE |
| 201469-31-0 | 3,4-Dehydro-L-proline hydrochloride |
| 201470-16-8 | Thiazole, 5-(1-ethoxyethenyl)- |
| 201470-17-9 | Ethanone, 2-bromo-1-(5-thiazolyl)- (9CI) |
| 201470-19-1 | Thiazole, 5-oxiranyl- (9CI) |
| 201470-73-7 | Furo[2,3-b]pyridine, 5-ethenyl- (9CI) |
| 201470-89-5 | Furo[2,3-b]pyridine-5-carboxaldehyde (9CI) |
| 201471-76-3 | 1,2-Benzenediol, 3-bromo-6-methyl- (9CI) |
| 201472-64-2 | 2-Oxabicyclo[4.1.0]heptan-3-one,6-(1-methylethyl)-,(1S)-(9CI) |
| 201472-65-3 | 3-Oxabicyclo[4.1.0]heptan-2-one,6-(1-methylethyl)-,(1S)-(9CI) |
| 201472-66-4 | BOC-DAB(BOC)-OH DCHA |
| 201472-68-6 | BOC-DAP(BOC)-OH DCHA |
| 201472-73-3 | Heptadecanoic Acid N-HydroxysucciniMide Ester |
| 201473-83-8 | FMOC-DAB(FMOC)-OH |